|
May 2013 |
|
May 16 |
Moving Genomics Closer to the Clinic |
|
May 2 |
Foundation Medicine, MSKCC Partner on Companion Dx for Hematologic Cancer Treatments |
|
April 2013 |
|
April 30 |
FasterCures Hosts Health Care Track at the Milken Global Conference |
|
April 30 |
QIAGEN Buys Genomic Data Analysis Firm Ingenuity Systems for $105M |
|
April 23 |
OHSU, Intel team up to develop technologies to make personalized genomic analysis faster |
|
April 22 |
GlaxoSmithKline in Drug-Discovery Deal |
|
April 19 |
Using Data To Treat Cancer and Drive Innovation |
|
April 10 |
Pfizer's Palbociclib gets FDA breakthrough label |
|
April 8 |
Charting Her Own Course-Telome Health |
|
April 8 |
Pharmacyclics and Johnson & Johnson Get New Breakthrough-Therapy Designation for Ibrutinib |
|
April 4 |
Foundation Medicine to Develop Dx for Agios Cancer Therapeutics |
|
April 2 |
Daratumumab Granted Fast Track Designation from US Food and Drug Administration |
|
April 2 |
Arup to Offer Predictive Bio's Bladder Cancer Dx |
|
April 1 |
Lab Group Tells CMS That Medicare Contractors Aren't Paying for MDx Tests With New CPT Codes |
|
March 2013 |
|
March 31 |
Novartis CEO Joe Jimenez lays out his path to business longevity |
|
March 27 |
Pfizer and Collaborators Developing Next-Gen Sequencing Test for Crizotinib Resistance Mutations |
|
March 27 |
Cleveland Clinic Rolls out EHR-based Program to Alert Docs about PGx Tests for Azathioprine, Abacavir |
|
March 26 |
PrimeraDx, Quest Co-developing MDx to Support Drug Development |
|
March 20 |
CardioDx Data Suggests Corus CAD May Reduce Additional Testing in Women at Low Risk of CAD |
|
March 15 |
Novartis compound LDK378 receives FDA Breakthrough Therapy designation for ALK+ non-small cell lung cancer |
|
March 13 |
Labceutics, Asuragen Conducting BCR-ABL Quality Assurance Study Among European Labs |
|
March 13 |
Forging a Path From Companion Diagnostics to Holistic Decision Support |
|
March 11 |
Biologics Research Promises to Bolster Future of Medicine-Report: More Than 900 Biologic Medicines and Vaccines in Development |
|
March 6 |
Saladax obtains $22.4m strategic equity investment from Shanghai Fosun Pharmaceutical |
|
March 5 |
Learn About Personalized Medicine at Penn State Hershey |
|
February 2013 |
|
February 26 |
Covance and M2Gen Enter into Alliance to Promote Faster Patient Recruitment in Biomarker-Driven Oncology Trials |
|
February 26 |
USF doctor leads team to discover DNA-heart failure link |
|
February 21 |
Quest Diagnostics Partners with Larry King Cardiac Foundation to Improve Access to Cardiac Testing |
|
February 18 |
Get to Know Your Genetic Counselor |
|
February 15 |
Caprion Leads New Personalized Medicine Partnership for Cancer |
|
February 14 |
Qiagen, Eli Lilly Enter CDx Deal |
|
January 2013 |
|
January 29 |
23andMe and Genentech Expand Cancer Study |
|
January 26 |
Institute for Personalized Medicine established by UPMC |
|
January 17 |
AMA Enhances Genetic Testing Registry |
|
January 15 |
Qiagen Submits EGFR Companion Dx to FDA |
|
January 8 |
Stanford researchers have discovered how a genetic mutation results in the leading cause of sudden cardiac death in young people, opening up new possibilities for preventive and patient-specific treatments. |
|
January 8 |
Life Tech, Boston Children's Hospital Launch New Company to Focus on Pediatric Disease Diagnostics |
|
January 3 |
The First Functionally Interpretable Systems Biology Platform for Personalized Medicine and Drug Development |
|
January 2 |
AbbVie Celebrates Launch as New Biopharmaceutical Company with Employees, Patients |
ShareThis